Trial and authors | Study population (n) | Prevalence of squamous cell cancers per 1000 at T0 | Average duration of screening (years) | Average annual incidence of confirmed squamous cell lung cancers per 1000 during screening | Lead time (years) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Intervention | Control | Intervention detected by SC alone (a) | Control detected by SC alone (b) | Intervention, detected by SC alone (c) | Intervention, interval cancers (d) | Control, CR- detected cancers (e) | Control, interval cancers (f) | a/(c + d) | a/(e + f) | ||
4618 | 4593 | 1.8 | 6 | 0.7 | 0.6* | Not applicable | 1.0* | 1.3 | 1.8 | ||
John Hopkins study: Frost et al. 1984 [10]; Doria-Rose et al. 2009 [11]b | 5226 | 5161 | 2.1 | Not applicable | 7.2 | 0.9 | 0.5 | 0.8 | 0.9 | 1.5 | 1.2 |
Memorial Sloan Kettering: Melamed et al. 1984 [12]; Doria-Rose et al. 2009 [11]b | 4968 | 5072 | 1.8 | Not applicable | 7.2 | 0.8 | 0.4 | 0.7 | 0.8 | 1.5 | 1.2 |